About Nerhadou
Nerhadou is a company based in Giza (Egypt) founded in 1996. Nerhadou has raised $20 million across 1 funding round from investors including Affirma Capital and StonePine Capital Partners. Nerhadou offers products and services including Multi-Amino Acids Chelates, ODF, and Natural Products. Nerhadou operates in a competitive market with competitors including ThinSol, BonAiyu Health, Aavishkar, EsoCap Biotech and InStar Technologies, among others.
- Headquarter Giza, Egypt
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20 M (USD)
in 1 rounds
-
Latest Funding Round
$20 M (USD), Series B
Feb 18, 2022
-
Investors
Affirma Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nerhadou
Nerhadou offers a comprehensive portfolio of products and services, including Multi-Amino Acids Chelates, ODF, and Natural Products.
Chelated amino acids for enhancing health and nutrition
Film technology for easy drug administration
Natural-based items for health improvement
Funding Insights of Nerhadou
Nerhadou has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series B round of $20 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nerhadou
Nerhadou has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Affirma Capital and StonePine Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acquisitions and buyouts are targeted by the private equity firm.
|
Locked | Locked | Locked | |
|
StonePine Capital Partners is focused on private equity investments.
|
Locked | Locked | Locked |
Investor details for Nerhadou
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nerhadou
Investment portfolio details for Nerhadou
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nerhadou
Detailed financials for Nerhadou
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nerhadou Comparisons
Peer comparison for Nerhadou
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nerhadou
Nerhadou operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ThinSol, BonAiyu Health, Aavishkar, EsoCap Biotech and InStar Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of oral thin strips for bioavailability and discreet administration
|
|
| Locked | Locked | Locked |
Mouth dissolving strips for nutritional supplements are provided.
|
|
| Locked | Locked | Locked |
Oral dissolving strips for OTC, Rx, and supplements are manufactured.
|
|
| Locked | Locked | Locked |
Topical drug delivery platform for upper GI disorders is developed.
|
|
| Locked | Locked | Locked |
Oro-mucosal delivery systems are developed via proprietary InStrip technology.
|
Detailed competitors of Nerhadou
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nerhadou
Complete news archive for Nerhadou
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nerhadou
Nerhadou was founded in 1996 and raised its 1st funding round 26 years after it was founded.
Nerhadou is headquartered in Giza, Egypt.
Nerhadou is a funded company, having raised a total of $20M across 1 funding round to date.
Nerhadou was established in 1996 in Giza, Egypt, within the health and pharmaceuticals sector. Multi-amino acids chelated products, including Ferrotron, Calcitron, Octatron, and Vitatron, are produced as nutritional supplements. Oral dispensable strips for drug delivery are also manufactured. Operations focus on formulation and development of these items for health applications, with distribution centered in the region.
Nerhadou's top competitors include Aavishkar, ThinSol and BonAiyu Health.
Nerhadou offers Multi-Amino Acids Chelates, ODF, and Natural Products.
Nerhadou has 2 investors. Key investors include Affirma Capital, and StonePine Capital Partners.